Applied Microbiology

Antimicrobials, Resistance & Novel Therapeutics

Antimicrobials, Resistance & Novel Therapeutics focuses on combating the global challenge of antimicrobial resistance (AMR) by understanding resistance mechanisms and developing next-generation treatments. Genomic surveillance, resistance gene detection, and molecular epidemiology reveal trends in drug-resistant pathogens across healthcare and community settings. Novel therapeutics including antimicrobial peptides, phage therapy, CRISPR-based antimicrobials, and microbiome modulation offer promising alternatives to traditional antibiotics. Drug repurposing, combination therapies, and targeted delivery systems enhance treatment effectiveness while minimizing toxicity. Innovative screening platforms accelerate discovery of new antimicrobial agents from natural and engineered sources. Stewardship programs, rapid diagnostics, and infection control practices play essential roles in slowing resistance spread. Addressing AMR requires cross-disciplinary collaboration spanning clinical microbiology, biotechnology, and public health. Advancements in understanding microbial adaptation support development of sustainable therapeutic solutions that protect global health.